Treatment Patterns, Outcomes and Testing in EGFRm NSCLC Patients With EGFR TKI 1L Across Europe (REFLECT)
NCT04031898
·
clinicaltrials.gov ↗
COMPLETED
Status
896
Enrollment
INDUSTRY
Sponsor class
Conditions
Lung Cancer
Interventions
OTHER:
Non Interventional
Sponsor
AstraZeneca